InvestorsHub Logo
Followers 785
Posts 38604
Boards Moderated 9
Alias Born 06/20/2009

Re: None

Monday, 09/19/2022 9:32:15 AM

Monday, September 19, 2022 9:32:15 AM

Post# of 64116

“Having used various stem cell therapies in my practice, including JadiCell, for which we are currently running a Phase III clinical trial, I have seen the potent effects this regenerative approach can have on many branches of medicine,” said Dr. James Veltmeyer, Chief Medical Officer of the Company, and co-inventor of the patent. “I am proud to be working with Ms. O’Connor and her team at Campbell Neurosciences in creating, what I believe to be, the first science-based approach to diagnosing and treating suicide as a disease and not a choice.”



https://newsfilter.io/a/84ed8eb2f2b95181a0b9a006dc6d7abc

hold'em accountable would figure Dr. James Veltmeyer, Chief Medical Officer & all involved would expect/know this


Alpha Male always Caribbean Wolf Pack Strong The Society of Slayers...

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TSOI News